LON:TRLS Trellus Health (TRLS) Share Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free TRLS Stock Alerts GBX 1.90 +0.15 (+8.57%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range 1.54▼ 250-Day Range 1.60▼ 4.2552-Week Range 1.50▼ 9.65Volume1.26 million shsAverage Volume314,268 shsMarket Capitalization£3.07 millionP/E Ratio190.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Trellus Health alerts: Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. About Trellus HealthTrellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.Read More TRLS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRLS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive TRLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trellus Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:TRLS CUSIPN/A CIKN/A Webwww.trellushealth.com Phone800-866-4165FaxN/AEmployees31Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.01 Trailing P/E Ratio190.00 Forward P/E RatioN/A P/E GrowthN/ANet Income£-7,540,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-29.34% Return on Assets-17.82% Debt Debt-to-Equity RatioN/A Current Ratio34.63 Quick Ratio17.11 Sales & Book Value Annual Sales£35,000.00 Price / Sales87.68 Cash FlowGBX 2.51 per share Price / Cash Flow0.76 Book ValueGBX 14 per share Price / Book0.14Miscellaneous Outstanding Shares161,510,000Free FloatN/AMarket Cap£3.07 million OptionableNot Optionable Beta0.18 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Marla Cindy Dubinsky M.D.Co-Founder, CEO & DirectorDr. Laurie Keefer Ph.D.Co-Founder & Chair of Scientific Advisory BoardMs. Joy Bessenger B.A.Chief Financial OfficerAled StevensonChief Operating OfficerJamey HancockChief Technology OfficerAmy MurphyDirector of Human ResourcesDr. Andres Jimenez M.B.A.M.D., M.S., Chief Medical Information OfficerLeah Conley M.B.A.Head of Global Market Access - Travere Therapeutics & Member of Scientific Advisory BoardMr. Salim Gulamabbas Hamir F.C.A.Company SecretaryMore ExecutivesKey CompetitorsIQ-AILON:IQAIDeepVergeLON:DVRGMotif BioLON:MTFBWidecells GroupLON:WDCFusion AntibodiesLON:FABView All Competitors TRLS Stock Analysis - Frequently Asked Questions How have TRLS shares performed in 2024? Trellus Health's stock was trading at GBX 3.25 on January 1st, 2024. Since then, TRLS stock has decreased by 41.5% and is now trading at GBX 1.90. View the best growth stocks for 2024 here. How do I buy shares of Trellus Health? Shares of TRLS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:TRLS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trellus Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.